XML 39 R29.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Other Income / (Expense) (Tables) | 3 Months Ended
--- | ---
Sep. 30, 2022
Notes Tables |
Schedule of the components of other income (expense) | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Quarter Ended
​ | ​ | September 30,
​ |  | 2022 |  | 2021
Interest expense | ​ | $ | (3,790) | ​ | $ | (3,409)
Interest income | ​ | ​ | 433 | ​ | ​ | 193
Other non-operating income (expense), net(1) | ​ |  | 50,756 | ​ |  | 7,377
Total other income (expense) | ​ | $ | 47,399 | ​ | $ | 4,161
​
(1) | Primarily due to a $37.2 million gain on the sale of our ChemoCentryx investment and a $11.7 million gain on the sale of Eminence.

X
- Definition Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items. + References No definition available. + Details
Name: | us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration